Recent findings suggest that CEACAM6 lactylation improves its stability, modulates cancer cell sensitivity to 5-fluorouracil, and induces chemotherapeutic resistance in CRC cell lines (HT29 and WiDr) (Chu et al., 2023). The gene discussed is CEACAM6; the disease is cancer.